from the American Association for Cancer Research (AACR).

Congratulations to Dr. Xi Tian for his receipt of an AACR-Aflac, Inc. Scholar-in-Training award. Dr. Tian is a postdoctoral fellow in Dr. Andy Wang’s laboratory, and studies nanotechnology-enabled cancer drug delivery to tumors.

Scholar-in-Training awards are highly competitive and are presented to fewer than 10% of applicants. The award recognizes outstanding young investigators for meritorious work in cancer research. Aflac, Inc. graciously donates funds to support young investigators who present high-quality, peer-reviewed papers at the AACR Annual Meeting. This year’s meeting will take place April 18-21, 2015 in Philadelphia, PA.